Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Hematology
Anemia
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
Iron Deficiency Anemia
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Iron Deficiency Anemia
A Phase II, Randomized, Open-Label, Comparative Study of Epoetin Alfa (Procrit) 80,000 Units or 120,000 Units Every Three Weeks Versus Darbepoetin (Aranesp) 500 mcg Every Three Weeks in Anemic Cancer Subjects Receiving Chemotherapy
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
An Anemia Clinic designed to evaluate a sequential referral population for the etiology of anemia across the adult age spectrum.
Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA). This is a study that is evaluating a drug referred to as Epoetin Alfa (erythropoietin) for treatment in people with anemia of unknown cause associated with advancing age.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Study to Investigate the Safety of FCM vs Standard Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Anemia - Chronic kidney disease
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Anemia - cancer
Anemia- cancer
Blood sample
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Blood sample
Blood sample
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Entrance into the International Fanconi Anemia Registry (IFAR)
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Blood Sample
Clinical Research Study for People with Cancer-related Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Have you been feeling grumpy, cranky, weak or dizzy?
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
Do you have Uterine Fibroids? Excessive Menstrual Bleeding? and Anemia?
Anemia due to Heavy Menstrual Periods
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
If you have a diagnosis of Iron Deficiency Anemia (IDA), please call us! We are conducting a multi-center, randomized, active controlled study of the efficacy and safety of intravenous Ferric Carboxymaltose (FCM)in patients with IDA.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Multi-center, Randomized, Active Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
This is a Phase IIIb, multi-center, open label, randomized, study that compares the safety and tolerabilty of Intravenous Ferric Carboxymaltose(FCM) vs. standard medical care in postpartum and heavy uterine bleeding subjects with iron deficiency
This is a Phase IIIb, multi-center, open label, randomized, study that compares the safety and tolerabilty of Intravenous Ferric Carboxymaltose(FCM) vs. standard medical care in postpartum and heavy uterine bleeding subjects with iron deficiency
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
(MARCH Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Advanced Cervical Cancer
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in Predialysis Patients With Renal Anemia
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) for Treatment of Anemia in Patients With Hematologic Malignancies.
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) for Treatment of Anemia in Patients With Hematologic Malignancies.
A Study of NeoRecormon (Epoetin Beta) for Treatment of Anemia in Patients With Hematologic Malignancies.
A Study of NeoRecormon (Epoetin Beta) for Treatment of Anemia in Patients With Hematologic Malignancies.
A Study of NeoRecormon (Epoetin Beta) for Treatment of Anemia in Patients With Hematologic Malignancies.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in Anemic Patients With Multiple Myeloma
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.
LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
(BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.
MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease Not Treated With ESA or on Dialysis.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease Not Treated With ESA or on Dialysis.
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease Not Treated With ESA or on Dialysis.
